These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 8917418

  • 1. Tamoxifen mediated human endometrial carcinogenesis may not involve estrogenic pathways: a preliminary note.
    Kuwashima Y, Kurosumi M, Kobayashi Y, Tanuma J, Suemasu K, Higashi Y, Kasamatsu T, Shiromizu K, Matsuzawa M, Kishi K.
    Anticancer Res; 1996; 16(5A):2993-6. PubMed ID: 8917418
    [Abstract] [Full Text] [Related]

  • 2. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M, Kodama T.
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [Abstract] [Full Text] [Related]

  • 3. A retrospective study of tamoxifen and endometrial cancer in breast cancer patients.
    Robinson DC, Bloss JD, Schiano MA.
    Gynecol Oncol; 1995 Nov; 59(2):186-90. PubMed ID: 7590470
    [Abstract] [Full Text] [Related]

  • 4. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma.
    Katase K, Sugiyama Y, Hasumi K, Yoshimoto M, Kasumi F.
    Cancer; 1998 May 01; 82(9):1698-703. PubMed ID: 9576291
    [Abstract] [Full Text] [Related]

  • 5. Iatrogenic endometrial megapolyps in women with breast carcinoma.
    Berezowsky J, Chalvardjian A, Murray D.
    Obstet Gynecol; 1994 Oct 01; 84(4 Pt 2):727-30. PubMed ID: 9205466
    [Abstract] [Full Text] [Related]

  • 6. Endometrial carcinoma following treatment for breast carcinoma in a Nigerian female. A case report and review of the literature.
    Abudu EK, Musa O, Adefuye PO, Abdul Kareem FB, Agboola AO, Banjo AA.
    Niger Postgrad Med J; 2007 Dec 01; 14(4):355-7. PubMed ID: 18163149
    [Abstract] [Full Text] [Related]

  • 7. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
    Sinawat S, Chiyabutra T, Kleabkaew P.
    J Med Assoc Thai; 2001 Jul 01; 84(7):1033-6. PubMed ID: 11759963
    [Abstract] [Full Text] [Related]

  • 8. Secretory endometrial adenocarcinoma in a tamoxifen user with breast cancer after menopause.
    Wu CJ, Peng YJ, Yu MH, Chen CH.
    Taiwan J Obstet Gynecol; 2007 Mar 01; 46(1):88-90. PubMed ID: 17389201
    [No Abstract] [Full Text] [Related]

  • 9. [Endometrial adenocarcinoma appearing during tamoxifen therapy. Report of a clinical case].
    Menada MV, Corticelli A, Giannesi A, Nicoletti L, Podesta M, Rissone R, Fulcheri E.
    Minerva Ginecol; 2000 Dec 01; 52(12):521-6. PubMed ID: 11310150
    [Abstract] [Full Text] [Related]

  • 10. Endometrial cancer and tamoxifen.
    Burke C.
    Clin J Oncol Nurs; 2005 Apr 01; 9(2):247-9. PubMed ID: 15853168
    [No Abstract] [Full Text] [Related]

  • 11. Endometrial cancer after tamoxifen treatment: a descriptive study of 25 breast cancer patients who subsequently developed endometrial cancer.
    Peters-Engl C, Medl M, Danmayr E, Mirau M, Alth G, Leodolter S.
    Anticancer Res; 1996 Apr 01; 16(5B):3241-6. PubMed ID: 8920798
    [Abstract] [Full Text] [Related]

  • 12. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
    Cheng WF, Lin HH, Torng PL, Huang SC.
    Gynecol Oncol; 1997 Aug 01; 66(2):233-7. PubMed ID: 9264568
    [Abstract] [Full Text] [Related]

  • 13. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
    Semiglazov VF, Maksimov SIa, Bulgatova EA, Meshkova IE, Chepik OF, Berstein LM.
    Vopr Onkol; 2003 Aug 01; 49(2):198-204. PubMed ID: 12785205
    [Abstract] [Full Text] [Related]

  • 14. Hormone receptor status of a contralateral breast cancer is independent of the receptor status of the first primary in patients not receiving adjuvant tamoxifen.
    Arpino G, Weiss HL, Clark GM, Hilsenbeck SG, Osborne CK.
    J Clin Oncol; 2005 Jul 20; 23(21):4687-94. PubMed ID: 15837971
    [Abstract] [Full Text] [Related]

  • 15. [Endometrial cancer and tamoxifen. Discussion apropos of a series of cases].
    Sasco AJ, Ah-Song R, Gendre I, Zlatoff P, Bobin JY, Hallonet P, Leduc B.
    Bull Cancer; 1997 Jan 20; 84(1):51-60. PubMed ID: 9180860
    [Abstract] [Full Text] [Related]

  • 16. [Tamoxifen and giant endometrial polyps].
    Caschetto S, Cassaro N, Consalvo P, Caragliano L.
    Minerva Ginecol; 2000 Nov 20; 52(11):459-63. PubMed ID: 11256174
    [Abstract] [Full Text] [Related]

  • 17. Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies.
    Cohen I, Beyth Y, Altaras MM, Shapira J, Tepper R, Cardoba M, Yigael D, Figer A, Fishman A, Berenhein J.
    Gynecol Oncol; 1997 Oct 20; 67(1):8-15. PubMed ID: 9345349
    [Abstract] [Full Text] [Related]

  • 18. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
    Swerdlow AJ, Jones ME, British Tamoxifen Second Cancer Study Group.
    J Natl Cancer Inst; 2005 Mar 02; 97(5):375-84. PubMed ID: 15741574
    [Abstract] [Full Text] [Related]

  • 19. [Cancer of the endometrium caused by antiestrogens].
    Le Bouëdec G, Dauplat J.
    Rev Fr Gynecol Obstet; 1992 Jun 02; 87(6):345-8. PubMed ID: 1631476
    [Abstract] [Full Text] [Related]

  • 20. Endometrial cancer in patients with breast carcinoma treated with tamoxifen: report of two cases and the literature overview.
    Sliwińska M, Wojtacki J, Sliwiński W.
    Med Sci Monit; 2000 Jun 02; 6(2):399-406. PubMed ID: 11208346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.